Pipeline
Powered by Molecule Pro™ and Molecule Dance™
Program
Modality
Indication
Discovery
Optimization
IND-Enabling
Clinical
Partner
Wholly Owned
MDR001
GPCR
Undisclosed
Potential Best-in-Class
MDR002
Allosteric Inhibitor
Oncology
MDR603
Undisclosed
Undisclosed
Potential First-in-Class
2 Programs
Allosteric Inhibitor
Oncology
Potential First-in-Class
MDR033
Protein Degradator
Oncology
Design as a Service
EMDR001
Allosteric Inhibitor
Oncology
Potential Best-in-Class
Listed Biotech
EMDR189
Undisclosed
Undisclosed
Listed Biotech
Co-developed
10+ Programs